Amos, C.I.* ; Dennis, J.* ; Wang, Z.* ; Byun, J.* ; Schumacher, F.R.* ; Gayther, S.A.* ; Casey, G.* ; Hunter, D.J.* ; Sellers, T.A.* ; Gruber, S.B.* ; Dunning, A.M.* ; Michailidou, K.* ; Fachal, L.* ; Doheny, K.F.* ; Spurdle, A.B.* ; Li, Y.* ; Xiao, X.* ; Romm, J.* ; Pugh, E.N.* ; Coetzee, G.A.* ; Hazelett, D.J.* ; Bojesen, S.E.* ; Caga-Anan, C.* ; Haiman, C.A.* ; Kamal, A.K.* ; Luccarini, C.* ; Tessier, D.C.* ; Vincent, D.* ; Bacot, F.* ; Van Den Berg, D.J.* ; Nelson, S.* ; Demetriades, S.* ; Goldgar, D.E.* ; Couch, F.J.* ; Forman, J.L.* ; Giles, G.G.* ; Conti, D.V.* ; Bickeböller, H.* ; Risch, A.* ; Waldenberger, M. ; Brüske, I. ; Hicks, B.D.* ; Ling, H.* ; McGuffog, L.* ; Lee, A.* ; Kuchenbaecker, K.B.* ; Soucy, P.* ; Manz, J. ; Cunningham, J.M.* ; Butterbach, K.* ; Kote-Jarai, Z.* ; Kraft, P.* ; Fitzgerald, L.A.* ; Lindström, S.* ; Adams, M.* ; McKay, J.D.* ; Phelan, C.M.* ; Benlloch, S.* ; Kelemen, L.E.* ; Brennan, P.* ; Riggan, M.* ; O'Mara, T.A.* ; Shen, H.* ; Shi, Y.Y.* ; Thompson, D.J.* ; Goodman, M.T.* ; Nielsen, S.F.* ; Berchuck, A.* ; Laboissiere, S.* ; Schmit, S.L.* ; Shelford, T.* ; Edlund, C.K.* ; Taylor, J.A.* ; Field, J.K.* ; Park, S.K.* ; Offit, K.* ; Thomassen, M.* ; Schmutzler, R.K.* ; Ottini, L.* ; Hung, R.J.* ; Marchini, J.* ; Amin Al Olama, A.* ; Peters, U.* ; Eeles, R.A.* ; Seldin, M.F.* ; Gillanders, E.* ; Seminara, D.* ; Antoniou, A.C.* ; Pharoah, P.D.* ; Chenevix-Trench, G.* ; Chanock, S.J.* ; Simard, J.* ; Easton, D.F.*
The OncoArray Consortium: A network for understanding the genetic architecture of common cancers.
Cancer Epidemiol. Biomarkers Prev. 26, 126-135 (2017)
BACKGROUND: Common cancers develop through a multistep process often including inherited susceptibility. Collaboration among multiple institutions, and funding from multiple sources, has allowed the development of an inexpensive genotyping microarray, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers and cancer related traits. METHODS: The OncoArray can be genotyped using a novel technology developed by Illumina to facilitate efficient genotyping. The consortium developed standard approaches for selecting SNPs for study, for quality control of markers and for ancestry analysis. The array was genotyped at selected sites and with prespecified replicate samples to permit evaluation of genotyping accuracy among centers and by ethnic background. RESULTS: The OncoArray consortium genotyped 447,705 samples. A total of 494,763 SNPs passed quality control steps with a sample success rate of 97% of the samples. Participating sites performed ancestry analysis using a common set of markers and a scoring algorithm based on principal components analysis. CONCLUSIONS: Results from these analyses will enable researchers to identify new susceptibility loci, perform fine mapping of new or known loci associated with either single or multiple cancers, assess the degree of overlap in cancer causation and pleiotropic effects of loci that have been identified for disease-specific risk, and jointly model genetic, environmental and lifestyle related exposures. IMPACT: Ongoing analyses will shed light on etiology and risk assessment for many types of cancer.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Genome-wide Association; Ovarian-cancer; Susceptibility Loci; Prostate-cancer; Endometrial Cancer; Lung-cancer; Breast-cancer; Risk Loci; Environment Interactions; Mendelian Randomization
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2017
Prepublished im Jahr
2016
HGF-Berichtsjahr
2016
ISSN (print) / ISBN
1055-9965
e-ISSN
1538-7755
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 26,
Heft: 1,
Seiten: 126-135
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Association for Cancer Research (AACR)
Verlagsort
Philadelphia
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology (EPI)
POF Topic(s)
30202 - Environmental Health
30503 - Chronic Diseases of the Lung and Allergies
80000 - German Center for Lung Research
Forschungsfeld(er)
Genetics and Epidemiology
Lung Research
PSP-Element(e)
G-504091-001
G-503900-001
G-501800-392
Förderungen
Copyright
Erfassungsdatum
2016-10-14